Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2023 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
XBIO on Nasdaq
Shares outstanding
2,291,515
Price per share
$2.77
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
228,794
Total reported value
$496,638
% of total 13F portfolios
0%
Share change
+170,656
Value change
+$355,037
Number of holders
11
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RENAISSANCE TECHNOLOGIES LLC 7.8% $403,430 178,509 Renaissance Technologies LLC 27 Oct 2025

As of 31 Dec 2025, 11 institutional investors reported holding 228,794 shares of Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO). This represents 10% of the company’s total 2,291,515 outstanding shares.

Institutional Holders of Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 228,794 $496,638 +$355,037 $2.17 11
2025 Q3 58,138 $183,741 -$25,655 $3.15 10
2025 Q2 64,211 $250,169 -$109,737 $3.92 9
2025 Q1 107,313 $292,493 +$46,588 $2.61 12
2024 Q4 89,449 $356,056 +$160,445 $4.00 13
2024 Q3 48,734 $211,621 +$146,292 $4.34 9
2024 Q2 14,882 $62,048 -$18,275 $4.07 5
2024 Q1 19,610 $73,775 +$10,085 $3.77 7
2023 Q4 16,935 $60,671 -$1,088 $3.45 7
2023 Q3 17,288 $79,405 -$44,568 $4.90 7
2023 Q2 36,642 $120,375 +$120,375 $3.28 9